CD8A and COVID-19: Comparing systemic immune population dynamics (Fig. 1C, D), we found significant increases in plasma B cells (cluster 6; p < 0.01), NK cells (cluster 10; p < 0.001), and terminally differentiated CD8+ T cells (cluster 12; p < 0.05) in baseline (D1) COVID-19 patients vs. healthy donors (HD).